Bancorp

TBBK · NASDAQ

$50.61+$1.23 (+2.49%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $49.38

TBBK analyst rating

BuyConsensus of 2 analysts over the last 12 months. 100% rate it a buy.

Strong buy0
Buy2
Hold0
Underperform0
Sell0

12-month price target · 5 analysts

Average $82.28 (+62.6% upside)

Low: $75.75
Now: $50.61
High: $92.40

Upgrades and downgrades

The latest rating actions, newest first

TBBK analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Piper Sandler	Sep 17, 2026	Maintains	Overweight	$86.00 → $75.00	46%
Keefe, Bruyette & Woods	Aug 3, 2026	Maintains	Outperform	$77.00 → $79.00	68%
Piper Sandler	Aug 3, 2026	Maintains	Overweight	$70.00 → $86.00	46%
Keefe, Bruyette & Woods	Jul 9, 2026	Upgrade	Market Perform → Outperform	$72.00 → $77.00	68%
Piper Sandler	Mar 12, 2026	Initiates	Overweight	$66.00	46%

The case for and against

Updated Oct 21, 2026

Bull case

Bancorp is attractive because its fintech franchise remains securely embedded with 50+ partners, a durable value proposition that would be costly and time-consuming for rivals to replicate, and management still sees roughly 70% of the revenue needed to support APEX 2030 growth already identified. The outlook is reinforced by multiple catalysts, including the Cash App ramp in late 4Q26E, two new credit sponsor programs in 2H26E, and the first embedded finance partner, alongside expected buybacks of about $50M per quarter in 2026E and near-100% total payout in 2027E. Fundamentally, earnings power is improving as Q2 showed stronger PPNR, better expense control, and advancing credit quality, with NCOs of 1.35% and criticized REBL assets down 22% to 2.1% of the portfolio.

Bear case

Bancorp is facing a deteriorating risk-reward profile as its CHYM relationship, which generated about 8% of 2Q26 core revenue and is still contractually locked through mid-2028, is expected to wind down after CHYM’s deal closes in 1H27E, pressuring revenue and driving a modeled 4% reduction in 2027E. Although the company is cutting 64 positions plus 16 unfilled roles to produce about $14M of annualized savings and $20M total run-rate savings, those benefits are largely offset by lower revenue, while NIM still slipped to 3.85% and could fall further to 3.81% by end-2026 and 3.78% by end-2027. Credit trends also look less supportive, with NPAs rising to 1.88% of loans and OREO, and the ongoing shift toward fintech lending adds fee dependence, regulatory exposure, and partner concentration risk rather than durable earnings stability.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.